文献速递心脑血管急症重症综合管理与镇静镇痛

C反应蛋白-白蛋白-淋巴细胞计数指数与接受再灌注治疗的急性缺血性卒中患者90天预后的相关性

[Correlation between the C-reactive protein-albumin-lymphocyte count index and the 90-day prognosis of patients with acute ischemic stroke undergoing reperfusion therapy].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2026-01-01
一句话结论CALLY指数是接受再灌注治疗AIS患者90天不良预后的独立保护因素,联合年龄和再灌注前NIHSS评分的预测模型AUC达0.823。

多因素logistic回归显示CALLY指数每升高1单位,90天不良预后风险降低4.2%(OR=0.958,95%CI 0.937-0.980,P<0.001),为独立保护因素。RCS模型显示非线性负相关,最佳截断值2.242,低于此值者预后不良风险显著升高,90天死亡率19.14% vs 11.82%(P<0.05)。CALLY指数单独预测AUC为0.630,联合年龄和再灌注前NIHSS评分的模型AUC提升至0.823(95%CI 0.800-0.846),最佳截断值0.322,灵敏度68.2%,特异度82.6%,预测准确率73.9%。

要点

  • CALLY指数每升高1单位,接受再灌注治疗AIS患者90天不良预后风险降低4.2%(OR=0.958,95%CI 0.937-0.980,P<0.001)。
  • CALLY指数最佳截断值为2.242,低于此值者90天死亡率显著高于高值组(19.14% vs 11.82%,P<0.05)。
  • CALLY指数单独预测90天不良预后AUC为0.630(95%CI 0.598-0.661),预测效能有限。
  • 联合年龄和再灌注前NIHSS评分的预测模型AUC为0.823(95%CI 0.800-0.846),最佳截断值0.322,灵敏度68.2%,特异度82.6%,准确率73.9%。
  • CALLY指数由发病24小时内CRP、白蛋白和淋巴细胞计数计算,与90天不良预后呈非线性负相关(非线性P<0.001)。

适用人群与场景

  • 2022年1月1日至2025年8月31日在中国科学技术大学附属第一医院神经内科接受再灌注治疗的急性缺血性卒中患者。
  • 纳入标准:接受再灌注治疗的AIS患者;排除标准原文未提及。

诊断标准与关键阈值

  • CALLY指数由发病24小时内检测的C反应蛋白、白蛋白和淋巴细胞计数计算得出。
  • 预后分组依据发病后90天mRS评分:0-2分为预后良好组,3-6分为预后不良组。
  • CALLY指数最佳截断值为2.242(依据RCS模型得出),低于此值定义为低CALLY指数组,高于或等于此值定义为高CALLY指数组。
  • 联合预测模型(CALLY指数+年龄+再灌注前NIHSS评分)最佳截断值为0.322。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 人群:预后良好组759例(mRS 0-2分),预后不良组494例(mRS 3-6分)。
  • 主要终点:90天mRS评分;CALLY指数为90天不良预后的独立保护因素,每升高1单位OR=0.958(95%CI 0.937-0.980,P<0.001),调整因素包括性别、年龄和既往病史。
  • RCS模型显示CALLY指数与90天不良预后呈显著非线性负相关(非线性P<0.001),最佳截断值2.242。
  • CALLY指数单独预测90天不良预后AUC=0.630(95%CI 0.598-0.661);联合年龄和再灌注前NIHSS评分模型AUC=0.823(95%CI 0.800-0.846),最佳截断值0.322,灵敏度68.2%,特异度82.6%,准确率73.9%。
  • 低CALLY指数组(<2.242,627例)90天死亡率19.14%(120/627),高CALLY指数组(≥2.242,626例)为11.82%(74/626),P<0.05。
  • 两组间年龄、高脂血症史、房颤史、再灌注前NIHSS评分、TOAST分型、再灌注治疗类型、住院天数、CRP、WBC、LYM、NEU、Alb及CALLY指数差异均有统计学意义(均P<0.05)。

证据类型、等级与局限

  • 证据类型:单中心回顾性病例对照研究。
  • 证据等级或推荐强度:原文未提及。
  • 局限:单中心、回顾性设计;原文未提及样本量估算、盲法或外部验证。

对床旁实践的改变

  • 对于接受再灌注治疗的AIS患者,可计算发病24小时内CALLY指数(基于CRP、白蛋白、淋巴细胞计数)辅助评估90天预后风险。
  • CALLY指数低于2.242提示90天不良预后和死亡风险较高,可考虑加强监护和早期干预,但原文未给出具体干预措施。
  • CALLY指数单独预测效能有限(AUC 0.630),联合年龄和再灌注前NIHSS评分的模型预测效能更优(AUC 0.823),可辅助临床决策。
  • 原文未提及该指数对治疗决策或干预措施的改变,不能据此推荐特定治疗。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the correlation between the C-reactive protein-albumin-lymphocyte count (CALLY) index and the 90-day prognosis of patients with acute ischemic stroke (AIS) undergoing reperfusion therapy, and to clarify its predictive value for the 90-day prognosis of these patients.

METHODS: A single-center retrospective case-control study was conducted. Patients with AIS who received reperfusion therapy in the Department of Neurology, the First Affiliated Hospital of the University of Science and Technology of China, from January 1, 2022, to August 31, 2025, were enrolled as the research subjects. Baseline clinical data, including demographic characteristics, medical history, pre-reperfusion National Institutes of Health Stroke Scale (NIHSS) score, Trial of Org 10172 in Acute Stroke Treatment (TOAST) classification, type of reperfusion therapy, and length of hospital stay, as well as laboratory indicators including C-reactive protein (CRP), white blood cell count (WBC), lymphocyte count (LYM), neutrophil count (NEU), and albumin (Alb) measured within 24 hours after symptom onset, were retrospectively collected from the hospital's electronic medical record system. The CALLY index was calculated accordingly. The 90-day modified Rankin Scale (mRS) score after onset was defined as the primary outcome. All enrolled patients were stratified into the good prognosis group (mRS score: 0-2) and the poor prognosis group (mRS score: 3-6). Baseline clinical and laboratory variables were compared between the two groups. Univariate and multivariate logistic regression analyses were performed to explore the association between the CALLY index and 90-day poor prognosis in AIS patients. A restricted cubic spline (RCS) model was applied to analyze the dose-response relationship between the CALLY index and the risk of poor prognosis. Receiver operator characteristic curve (ROC curve) analysis was used to evaluate the predictive efficacy of the CALLY index alone and in combination with other indicators for 90-day poor prognosis in patients with AIS.

RESULTS: Finally, a total of 1 253 AIS patients who received reperfusion therapy were enrolled in this study, including 759 patients in the good prognosis group and 494 patients in the poor prognosis group. Baseline analysis showed significant differences between the two groups in age, history of hyperlipidemia, history of atrial fibrillation, pre-reperfusion NIHSS score, TOAST classification, treatment type, length of hospital stay, and levels of CRP, WBC, LYM, NEU, and Alb, as well as the CALLY index (all P<0.05). Univariate and multivariate logistic regression analyses revealed that the CALLY index was significantly negatively correlated with 90-day poor prognosis in AIS patients (all P<0.05). After adjusting for confounding factors including gender, age, and previous medical history, each 1-unit increase in the CALLY index reduced the risk of 90-day poor prognosis in AIS patients by 4.2% [odds ratio (OR) = 0.958, 95% confidence interval (95%CI) was 0.937-0.980, P<0.001], indicating that the CALLY index was an independent protective factor against poor 90-day prognosis in AIS patients. The RCS model confirmed a significant nonlinear negative correlation between the CALLY index and 90-day poor prognosis (nonlinear P<0.001), with an optimal cutoff value of 2.242. Patients with a CALLY index below this cutoff value had a significantly higher risk of poor prognosis. ROC curve analysis demonstrated that the AUC of the single CALLY index for predicting 90-day poor prognosis was 0.630 (95%CI was 0.598-0.661). The binary logistic regression prediction model established by combining the CALLY index with age and pre-reperfusion NIHSS score yielded an increased AUC of 0.823 (95%CI was 0.800-0.846), with an optimal cutoff value of 0.322, a sensitivity of 68.2%, a specificity of 82.6%, and a predictive accuracy of 73.9%. Based on the RCS-derived cutoff value of 2.242 for the CALLY index, all enrolled patients were divided into the low CALLY index group (CALLY index<2.242, 627 cases) and the high CALLY index group (CALLY index≥2.242, 626 cases). Significant differences existed between the two groups in age, history of hyperlipidemia, history of atrial fibrillation, pre-reperfusion NIHSS score, TOAST classification, reperfusion therapy type, length of hospital stay, CRP, WBC, LYM, NEU, Alb, and 90-day mRS score (all P<0.05). Moreover, the low CALLY index group had a significantly higher 90-day mortality rate than the high CALLY index group [19.14% (120/627) vs. 11.82% (74/626), P<0.05].

CONCLUSIONS: The CALLY index serves as an independent protective factor for the 90-day prognostic outcome in AIS patients receiving reperfusion therapy. The combined prediction model incorporating the CALLY index, age, and pre-reperfusion NIHSS score exhibits superior predictive efficacy for clinical prognosis.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Hu Q, Xu S, Chen X, et al. [Correlation between the C-reactive protein-albumin-lymphocyte count index and the 90-day prognosis of patients with acute ischemic stroke undergoing reperfusion therapy]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2026. PMID: 42427326. doi:10.3760/cma.j.cn121430-20260201-00067

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。